AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

2024 Oral Presentations

“Tranq Burn”: Exploring the Etiology of Tranq-Related Soft Tissue Injuries Dan Ciccarone, MD, MPH; University of California, San Francisco

“Expedited Referrals” from SSP to OTP: Innovative Approaches to Reducing Barriers to Methadone Treatment for Patients Who Use Opioids and Experience Homelessness Natalie Stahl, MD, MPH1, Avik Chatterjee, MD, MPH2, Rebecca Weiner, MD1, Amy Bositis, MSN1; (1)Greater Lawrence Family Health Center, (2)Boston University Chobanian & Avedisian School of Medicine

“Just be Relentless,” Lessons Learned from in-Hospital Addiction Consult Service Implementation Beth E Williams, AGNP, MPH; Oregon Health & Science University

“The Go-To Response Is Let’s Get Them Back in Here”: Factors Influencing Adoption of Low-Barrier Treatment Practices in Outpatient Buprenorphine Maggie Lowenstein, MD, MPhil, MSHP; Penn Center for Addiction Medicine and Policy; University of Pennsylvania Perelman School of Medicine

“They Treat Me Differently Now”: Two Disparate Responses to in-Hospital Substance Use Taylor S Baisey, MPH1, Johanna Sluser, FNP-C, MSN1; (1)University of California, San Francisco

”Un Attracteur De Soins”: Bringing People into Care. Qualitative Study of Interprofessional French Healthcare Clinicians’ Attitudes Towards Opioid Agonist Therapy Honora L. Englander, MD; Service Universitaire d’Addictologie de Lyon, CH Le Vinatier, Hospices Civils de Lyon, Oregon Health & Science University

“You Need to Prove That What You Say Is True”: Patient Experiences with Urine Drug Testing in Buprenorphine Treatment Andrea U Jakubowski, MD, MS1, Isabel H Lamont, BCPS1, Mariya Masyukova, MD, MS2; (1)Montefiore Medical Center/Albert Einstein College of Medicine, (2)Project Renewal, Inc.

“You Want to Know the Person That’s Lying There”: Patient Experiences of Hospital-Based Care after a Stimulant-Related Overdose Isabel H Lamont, BCPS; Montefiore Medical Center/Albert Einstein College of Medicine

A Qualitative Assessment of Healthcare Experiences of Patients Engaged By the Reach Medical Outreach Model of Care to People Who Use Drugs in Ithaca, New York Simon Gagliardi, BA; Weill Cornell Medical College

A Qualitative Assessment of the Care Transition Experience of Patients with Substance Use Disorders after Hospital Discharge Michael Incze, MD, MSEd; Annika Hansen, MA; Shanaya Fox, BS; Carolyn Bell, MD; Danielle Babbel, MD – University of Utah

A Qualitative Exploration of the Substance Use Impacts of a Large-Scale Hoteling Intervention for People Experiencing Homelessness in NYC during the COVID-19 Pandemic Hannah Passmore, MPH; New York University Grossman School of Medicine

A Qualitative Investigation of Methadone Treatment Experiences, Facilitators, and Barriers Among People Experiencing Homelessness with Opioid Use Disorder Marina Gaeta Gazzola, MD; The APT Foundation Inc., NYU Grossman School of Medicine and Bellevue Hospital Center

Accessibility to Opioid Treatment Programs (OTPs) Via Personal Vehicle Versus Mass Transit across Census Block Groups in Connecticut Benjamin A. Howell, MD, MHS, MPH; Yale University School of Medicine

Adaptation, Implementation and Evaluation of Telementoring Echo Series to Address E-Cigarette Use Among Middle and High School Students in Kansas Babalola Faseru, MD, MPH; University of Kansas Medical Center

Adaptations Made By Post-Overdose Outreach Programs in Massachusetts Since the Onset of COVID-19 Allyson G. Cogan, MPH; Boston Medical Center

An Interprofessional Case-Based Discussion on Opioid Use Disorder: Influencing Knowledge, Confidence and Stigma Among Future Prescribers Katherine Grandinetti, MPH; University of Michigan Medical School

Association of Surgery with Discontinuation of Buprenorphine for the Treatment of Opioid Use Disorder Kyle R Buchwalder, MD; University of Michigan – School of Public Health

Associations between HIV Primary Care Provider Characteristics and Harm Reduction Acceptability: A Mixed-Methods Study Mary Hawk, LSW, DrPH; University of Pittsburgh

Attitudes Toward Medications for Opioid Use Disorder Among Residents in Low-Threshold Harm Reduction Housing Sites in Boston Avik Chatterjee, MD, MPH; Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine

Attributes of Higher- and Lower-Performing Hospitals in the Consult for Addiction Treatment and Care in Hospitals (CATCH) Program Implementation: A Multiple-Case Study Carla King, MPH; New York University Grossman School of Medicine

Barriers and Facilitators of Medication for Opioid Use Disorder (MOUD) in Skilled Nursing Facilities (SNFs) Justina L Groeger, MD, MPH1, Kristine E. Torres-Lockhart, MD1; (1)Montefiore Medical Center/Albert Einstein College of Medicine

Beyond the X-Waiver: Perspectives on Buprenorphine Access & Barriers in the Outpatient Setting Maggie Lowenstein, MD, MPhil, MSHP; Penn Center for Addiction Medicine and Policy; University of Pennsylvania Perelman School of Medicine

Buprenorphine in Jails: An Innovative Mixed-Methods Pilot Project in Rural Appalachia Robert Lyle Cooper, PhD1, Loren Deborah Ginn, MSSW1; (1)Meharry Medical College

Buprenorphine Induction As a Support for Families with Child Protective Services (CPS) Involvement Matthew Holm, MD1, Zina Huxley-Reicher, MD2; (1)Montefiore Medical Center/Albert Einstein College of Medicine, (2)NYC Health + Hospitals/Woodhull Medical and Mental Health Center/NYU

Buy and Bill Vs Patient Supplied XR Bup: A Nursing Administration Perspective Charina Hanley, BSN, RN, CARN; Boston Health Care for the Homeless Program

Caring for Individuals with Substance Use Disorder during Childbirth: Experiences of Rural Healthcare Providers Assumpta S Nantume, MSc; University of Utah

Centering a Harm Reduction Framework for Substance Use Disorder Counseling in Medical Student Education: A Pilot Curriculum Ana Malfa, BA1, Katie Zechnich, BA1; (1)The Warren Alpert Medical School of Brown University 

Changes in Buprenorphine Prescribing Among Pregnant and Postpartum Individuals Following Postpartum Medicaid Expansion in South Carolina Kristin C Prewitt, MD, MPH1, Megan Fuerst, MD, MPH1; (1)Oregon Health & Science University

Co-Developing and Implementing a Promotor Curriculum: Program for Education in Drugs and Alcohol for Latine (PEDAL) Marlene Martin, MD1, Triveni DeFries, MD, MPH1; (1)University of California, San Francisco

Code Bupe: Implementing Post-Overdose EMS Buprenorphine Programs across Missouri Rachel Winograd, PhD; University of Missouri, St. Louis

Collocated Care: A Peripartum Clinic at the Heart of the Opioid Epidemic Nia M Bhadra-Heintz, MD, MSc1, Navid Roder, MD1; (1)Hospital of the University of Pennsylvania

Combined Contingency Management for Stimulant Use Disorder and ART Adherence: An Implementation-Effectiveness Pilot in HIV Primary Care Gabriela Milagro Steiner, Medical Student, MSc; University of California, San Francisco

Comparing Long-Acting Injectable Versus Oral HIV Antiretroviral Therapy for People Who Use Drugs Kathleen O’Connor, Medical Student1, Nicky J Mehtani, MD, MPH2; (1)SFDPH- Whole Person Integrated Care, (2)University of California, San Francisco

Creating Clinical Partnerships with Law Enforcement to Support for People Who Use Drugs Using a Harm Reduction Lens Gilly Gehri, BA1, Nicole O’Donnell, CRS1; (1)University of Pennsylvania

Curriculum for Pediatric Residents on SBIRT in Primary Care Margaret Shang, MD; University of Pittsburgh Medical Center

Demand and Supply of Telemedicine Services for Racial and Ethnic Minority High Schoolers Affected By Violence and Substance Use During the Pandemic Chuka Nestor Emezue, MPA, MPH, PhD; Rush University Medical Center

Development and Implementation of a 24/7 State-Wide Telehealth Hotline for Initiation of Buprenorphine for People with OUD in Washington State Olivia P Hood, MPH; University of Washington

Development and Training for Peer-Delivered Contingency Management for Stimulant Use Harm Reduction across Oregon Linda Peng, MD1, Erin Stack, MSc2; (1)Oregon Health & Science University, (2)Comagine Health

Disparities in Patterns of Prescription Stimulant Use for ADHD in US Children Jennie E Ryan, CRNP, PhD; Thomas Jefferson University

Early Results of a Rapid Methadone Titration Initiation Protocol for Hospitalized Patients with Opioid Use Disorder Marlene Martin, MD1, Leslie W. Suen, MAS, MD1; (1)University of California, San Francisco

Effectiveness of the NO Stigma Simulation Suite in Reducing Stigma and Improving Attitudes and Empathy in Opioid Use Disorder Care: A Pilot Study Mary K. McCurry, ACNP, ANP-BC, PhD, RN-BC; University of Massachusetts Dartmouth

Embedding and Sustaining Peers in Emergency Departments: Exploring Program Implementation and Outcomes Jasmine S Barnes, MPH; University of Pennsylvania

Empowering Harm Reduction: A Cost-Efficient Training Program for Contingency Management in Syringe Services Programs Gaurika Mester, Medical Student1, Katrina Ciraldo, MD1; (1)University of Miami, Miller School of Medicine

Enhancing Family Engagement in Substance Use Disorder Treatment: A Training Intervention for Addiction Professionals Alicia S Ventura, MPH; Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center

Evaluating an Atlantic Canadian Injectable Opioid Agonist Treatment Program from the Perspective of Program Users Adrienne N Thornton, BS; University of New Brunswick 

Evaluating the Quality of Medication Assisted Treatment for Opioid Use Disorder in New Jersey County Jails: A Comprehensive Needs Assessment Approach Pamela Valera, PhD1, Clement Chen, PharmD2; (1)Rutgers University School of Public Health, (2)Rutgers University New Jersey of Medical School, The CARE Center Northern NJ Medication-Assisted Treatment Center of Excellence (COE)

Evaluation of the Clinical Efficacy of an Application to Support Prescribing of Medication for Addiction Treatment Andrea M Jodat, CARN-AP, DNP, FNP-BC; Boston Medical Center

Exploring Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations for Use Sarah Leyde, MD1, Joseph O Merrill, MD, MPH2; (1)University of Washington, Harborview Medical Center, (2)University of Washington

Exploring Drug Checking Services for People Who Use Drugs and Harm Reduction Staff: Post-Implementation Study Whitney A Ludwig, MPH; University of Michigan

Feasibility and Learner Experience in a Multidisciplinary Addiction Training Program Joshua D Lee, MD1, Talia Rosen, BA1; (1)New York University Grossman School of Medicine

Female Veterans: 20-Year Trends of Access and Episodes of Buprenorphine for Opioid Use Disorder within the Veterans Health Administration Sophia Huebler, MSc; University of Utah

From Clinic to Consult Service: Navigating a Case of Ketamine Withdrawal Jose Alejandro Castellanos, MD1, Cory Johnson, MD, MPH1, Johanna Sluser, FNP-C, MSN1; (1)University of California, San Francisco

From Conception to Dissemination: Utilizing a Black-Led Community Advisory Board to Advance Racial Equity in Substance Use Research Kaytryn D Campbell, MA, MSc; University of Missouri, St. Louis

Harm Reduction Based Contingency Management for Stimulant Use Disorder Surabhi Nirkhe, MD1; Meredith Adamo, MD2; (1)New York City Health + Hospitals/Bellevue, (2)San Francisco Department of Public Health

Harm Reduction in a Cocaine Research Study: A Case Report Zachary Davis, Medical Student1, Lily Margaret Caglianone, BS1, Veronica M Bucci, BS1; (1)University of Illinois Chicago

Harm Reduction in Peer-Assisted Telemedicine for Hepatitis C: Secondary Outcomes of a Randomized Controlled Trial Hunter C. Spencer, DO, AAHIVS; Oregon Health & Science University

Harm Reduction Supply Distribution Via Vending Machines: 8-Month Outcomes for a California Veterans Affairs Health Care System Tessa Lynne Rife-Pennington, PharmD, BCGP; San Francisco Veterans Affairs Health Care System, University of California, San Francisco

Healing the ’Non-Healing’: A Holistic Approach to Treating Xylazine-Associated Wounds Tehya Johnson, AGPCNP-BC1, Christina Bailey, CARN, MSN, RN1; (1)Boston Health Care for the Homeless Program

Hearing Hope: The Power of Narrative Storytelling in Addiction Medicine Brittany L Carney, DNP, FNP-BC; Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center

High-Dose Fentanyl and Buprenorphine Continuation As Support for the Treatment of Buprenorphine Precipitated Withdrawal Erik S Anderson, MD1, Megan Heeney, MD1, Kay R Lind, MD1; (1)Highland Hospital – Alameda Health System

Hospital-Based Navigation: A Tool for Linking Patients to Residential Addiction Treatment Sophie Zhai, BA; University of California, San Francisco

Implementation of a Substance Use Curriculum in an Academic Medical Center: Strategies to Expand Treatment of Substance Use Disorder Gilly Gehri, BA; University of Pennsylvania

Implementation of Post-Overdose Outreach Program Strategies and Toolkit Modules for Overdose Survivors Who Use Cocaine and Methamphetamine Sarah M. Bagley, MD; Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine

Implementation of Universal Screening for Posttraumatic Stress Disorder (PTSD) in an Opioid Treatment Program Alicia Wiprovnick, PhD; University of Maryland School of Medicine

Improving Alcohol Use Disorder Diagnosis and Treatment in a Primary Care Setting Using a Clinical Decision Support System Kevin Michael Pearlman, MD1, Mim Ari, MD1; (1)University of Chicago

Improving the Hospital Care Environment for People Who Use Drugs Jillian Zavodnick, MD1, Katie Mechler, MD1; Natalina Contoreggi, MD; Helene Dailey, DNP, RN, CCRN, CCCTM; Rebecca Jaffe, MD; (1)Thomas Jefferson University

An Interprofessional Model for Treating Alcohol Use Disorder in a Public Hospital Triveni DeFries, MD, MPH; University of California, San Francisco

Evaluation of Outcomes of Extended-Release Buprenorphine Administered during Emergency Department and Inpatient Visits Megan Heeney, MD1, Erik S Anderson, MD1, Robert Benard, ACNP, PMHNP-BC1; (1)Highland Hospital – Alameda Health System 

Reduced Emergency Department Use Among Insured Individuals Receiving Extended-Release Buprenorphine in a Health System Setting Sarah J Leitz, MD; Kaiser Permanente

Tianeptine Use Disorder Treated with Methadone Maintenance: A Case Report Morgan Avery, MPH, PA-C; University of Colorado School of Medicine

“Nothing about Us without Us, Is for Us”: Creating a Harm Reduction Veteran Engagement Board to Inform Program Development Beth Dinges, PharmD; VA Illiana Healthcare System

Patients Perceptions of Physical Therapists Addressing Hazardous Drinking: A Cross-Sectional Study John Magel, PT, PhD, DSc; University of Utah

Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals Erin C Nacev, MD, MPH1, Kristin C Prewitt, MD, MPH1; (1)Oregon Health & Science University




“It Wasn’t to Get High; It Was Just to Get By”: A Study of the Experience of Patients Who Use Illicitly Manufactured Fentanyl during Methadone Treatment and Recommendations to Improve Care Delivery in Vermont and New Hampshire; Jesse S Boggis, MPH ; Geisel School of Medicine at Dartmouth College

Increases in PrEP Awareness but Not PrEP Use Among People Who Inject Drugs Hunter C. Spencer, DO, AAHIVS; Oregon Health & Science University

It’s Complicated: A Peer-Taught Cannabis Prevention Education Program Emma R Wilson, BA; PreventEd

Long-Acting Injectable Antiretroviral Treatment Retention Among People with HIV Who Use Drugs Nicky J Mehtani, MD, MPH; University of California, San Francisco

Low-Dose Buprenorphine Initiation with and without 3 Days of Dispensed Methadone Among Patients at a Low-Threshold Addiction Clinic Lysa Samuel, PA1, Erik S Anderson, MD1; (1)Highland Hospital – Alameda Health System

Lower the Barriers: Treatment of Hepatitis C in an Opiate Treatment Program Laura Pugh, MD; University of California, San Francisco

Mechanisms of Overdose from Unintentional Fentanyl Use Among People Who Use Stimulants: A Qualitative Study Bryson O Gomez, Medical Student; University of California, San Francisco

Medications for Opioid Use Disorder (MOUD) in Massachusetts’ County Houses of Correction: Preliminary Findings on Post-Release Moud Treatment, Overdose, Reincarceration and Mortality Peter D Friedmann, MD, MPH; Baystate Health

Mobile Clinic for Individuals with Opioid Use Disorder: A Qualitative Analysis Cynthia A Tschampl, PhD; Brandeis University

Multi-Disciplinary Process for Patient-Centered Decisions on Take Home Medication in the Setting of Positive Toxicology in a Large, Urban Opioid Treatment Program Ari Kriegsman, MD1, Carissa Cutler, LICSW1, Hazel Barrett, LPN1; (1)Behavioral Health Network

Multi-Site Harm Reduction Kit Implementation and Distribution Margaret Shang, MD1, Raagini Jawa, MD2; (1)University of Pittsburgh Medical Center, (2)University of Pittsburgh

Non-Abstinence Among US Adults in Recovery: Findings from the 2022 National Survey on Drug Use and Health Emily Pasman, LMSW, PhD; University of Michigan

Nonprescription Syringe and over-the-Counter Naloxone Availability in Community Pharmacies: A Secret Shopper Purchase Audit in Austin, TX Shannon R Mayberry, BS, PharmD Candidate1, Jennifer E Lines, PharmD Candidate1; (1)The University of Texas at Austin College of Pharmacy

One Year in: The Impact of Addiction Consult Services in Improving Care for Hospitalized Patients with Substance Use Disorders M Holliday Davis, Clinical Research Coordinator; Center for Addiction Medicine and Policy, University of Pennsylvania

Operationalization of Long-Acting Pre-Exposure Prophylaxis for Socially Vulnerable Populations Sydney Yoon, BA; San Francisco Department of Public Health

Opioid Agonist Treatment Initiation Practices By Hospital-Based Addiction Consult Services Elana R Straus, BA, Medical Student; Yale University School of Medicine

Opioid-Induced Amenorrhea – Exploring the Impact of Chronic Opioid Use on Reproductive Health Safina Adatia, MD, MSc; Boston Medical Center

Outpatient Induction Using a 7-Day Extended-Release Injectable Buprenorphine for Patients with Opioid Use Disorder: Clinical Cases Elizabeth Ferro, MD; University of Pennsylvania

Pain Control and Self-Directed Discharge Among Hospitalized People with Opioid Use Disorder Michele J Buonora, MD, MHS, MSc; Montefiore Medical Center/Albert Einstein College of Medicine

Pairing Xylazine Education and Home Testing As a Harm Reduction Strategy for Pregnant and Postpartum Persons Who Use Illicit Opioids Ilana Hull, FASAM, MD, MSc1, Ellen Stewart, BS2; (1)University of Pittsburgh, (2)Magee Womens Research Institute

Patient and Navigator Experiences with the Opioid Use Disorder Treatment System in Philadelphia, Pennsylvania Megan K Reed, MPH, PhD; Thomas Jefferson University

Patient Characteristics Associated with Receipt of Contingency Management for Stimulant Use Disorder in the Veterans Health Administration Madeline C Frost, MPH, PhD; Veterans Affairs Puget Sound Healthcare System

Peer Led Substance Use Disorder Navigation to Support Reentry for Returning Citizens Nicole O’Donnell, BA; University of Pennsylvania

Peer Recovery Coach (PRC) As an Intervention for Incarcerated Individuals with Opioid Use Disorder (OUD): Perceptions from Staff Elizabeth Haberkorn, DNP, FNP-BC; University of Michigan

Perspectives of Mothers with Substance Use Disorder on Naloxone Education: “I’m Ready to Have Those Conversations about Who I Was, Because That’s Not Who I Am” Jessica B Calihan, MD, MSc; Boston Children’s Hospital

Pilot Evaluation of a Novel, Cooperative Opioid Use Disorder (OUD) Board Game Molly A. Nichols, MSc, PharmD; Purdue University College of Pharmacy

Polysubstance-Involved Opioid Overdose Deaths Among US Youth, 2020 to 2023 Connor Buchholz, MSc1, Scott E Hadland, MD, MPH, MSc2, Meredith Glass, MPH2; (1)Boston University School of Public Health, (2)Massachusetts General Hospital

Preparing Colorado Health Professionals in Primary Care and School-Based Health Centers (SBHCs) to Intervene Early for Adolescent Substance Use through Screening, Brief Intervention, and Referral to Treatment (SBIRT) Nora M Marino, MPH; NORC at the University of Chicago

Preparing Healthcare Workers to Discuss Harm Reduction with Patients Who Use Drugs through a Brief Workshop Patricia Moreno, BS; University of California, San Francisco

Provider Experiences of Substance Use-Related Disorder Management in Pediatric Hospitals: A Qualitative Analysis of Key Informant Interviews Adam Kronish, MD; Children’s Hospital of Philadelphia

Providers’ Knowledge and Perception of Xylazine in the Unregulated Drug Supply: A Sequential Explanatory Mixed-Methods Study Katherine Hill, BA, MPH, PhD Candidate; Yale School of Public Health

Public Perceptions of Opioid Misuse Recovery and Related Resources in a Nationally Representative Sample of U.S. Adults Olivia Golan, PhD; NORC at the University of Chicago

Public Transit Access to Methadone Treatment in Miami-Dade County, Florida Marina Plesons, MPH; University of Miami Miller School of Medicine

Rapid Transition from a Continuous Naloxone Infusion to Sublingual Buprenorphine after an Opioid Overdose Anthony Spadaro, MD, MPH1, Emily A Gordon, MD1; (1)Rutgers New Jersey Medical School

Rebuilding Hope: A Contingency Framework for Stimulant Use Among Unhoused Anusha Chandrakanthan, FAAFP, MD; Valley Homeless Healthcare Program, Santa Clara Valley Medical Center

Reimagining Recovery: A Health Justice-Oriented Training for Professionals By Michigan State University Extension Lauren E Kennedy, PhD; Michigan State University Extension

Rethinking Harm Reduction Conversations: An Oronasal Fistula in a Woman Snorting Xylazine-Fentanyl Elizabeth Ferro, MD; Allegheny Health Network

Reversal of Opioid Overdose with Intravenous Buprenorphine and Rapid Transition to Extended-Release Buprenorphine Josh Luftig, PA-C1,2, Michelle Patregnani, MD1; (1)Highland Hospital – Alameda Health System, (2)CA Bridge

Risk Factors for Chronic Pain Among People Who Inject Drugs in Denver, CO and Los Angeles, CA, 2021/22 Jimi Huh, PhD; University of Southern California 

Risk Perceptions, Parental Substance Use, and Peer Disapproval Predict Early Onset Substance in Adolescents with Comorbid Psychologic and Somatic Symptom Trajectories Sarah A Stoddard, FAAN, PhD, RN; University of Michigan

Rural Community Pharmacist Knowledge of Drug Checking Test Strips and Willingness to Engage with Test Strip Activities Grace T Marley, PharmD; University of North Carolina Eshelman School of Pharmacy, South East Area Health Education Center, University of North Carolina Wilmington

Rural Pregnant Women with Substance Use Disorder: A Grounded Theory Study Cami Weber, MBA, PhD, RN; Webster University

Scaling a Virtual Buprenorphine Bridge Clinic: Outcomes and Lessons Learned Patrick Joseph Dooley1, James S. Sherman, CPS1; (1)University of Pennsylvania

Search and Seizure: A Descriptive Analysis of Hospital Searches Among Patients with Substance Use Disorders Sarah Nessen, BA, Medical Student; Perelman School of Medicine, University of Pennsylvania, Penn Center for Emergency Care and Policy Research, Penn Center for Addiction Medicine and Policy

Self-Reported Readiness to Change Alcohol Use in Emergency Department Patients with Alcohol Use Disorder Predicts Successful Linkage to Treatment Caitlin R Ryus, MD, MPH; Yale University School of Medicine

Silent Struggles: Unveiling Stigma in Healthcare with Perinatal Opioid Use Disorder Rebecca Schapiro, MD1, Nia M Bhadra-Heintz, MD, MSc1; (1)Hospital of the University of Pennsylvania

Stigma-Free Access to Harm Reduction Supplies: A Cross-Sector Approach Shelby Arena, BA; MATTERS – UBMD Emergency Medicine

Student Led Harm Reduction Outreach: Educational and Community Impact Eli M Solomon, Medical Student; University of California, San Diego, Harm Reduction IHC 

Suicidal Ideation Among Non-Psychiatric Patients with Opioid Use Disorder in an Urban Emergency Department: Correlates and Future Overdose Events Lauren K Whiteside, MD; University of Washington

Supporting Hospitalized Adults with Stimulant Use Disorder Using a Mobile App Contingency Management Program Linda Peng, MD; Oregon Health & Science University

Surmounting Stigma: Missouri First Responder Attitudes Towards People Who Use Drugs Improve Following Training Saad T Siddiqui, MPH; Missouri Institute of Mental Health

Systematically Testing the Evidence on Marijuana Devan Kansagara, MCR, MD; Oregon Health & Science University

Telemedicine Hotline to Improve Access to Medications for Opioid Use Disorder — Illinois and MAR NOW Nicole Gastala, MD1, Maria Bruni, PhD2; (1)Substance Use Prevention and Recovery Division, (2)Family Guidance Centers, Inc.

Test Your Drugs, Not Your Limits: Advanced Drug Checking As an Enhancement to Harm Reduction and Medical Services at a Community Health Center Allyson Pinkhover, MPH; Brockton Neighborhood Health Center, Johns Hopkins University Bloomberg School of Public Health

The Civil Right to Medication for Opioid Use Disorder Amelia Caramadre, JD, MPH1; Ruchi V Shah, DO2; (1)Kaplan & Grady, LLC, (2)Boston Medical Center

The Good, the Bad, and the Ugly: Patient Perspectives on Low Dose Buprenorphine Initiation in the Outpatient Setting in the Fentanyl Era Leslie W. Suen, MAS, MD; University of California, San Francisco 

The Impact of Anti-Stigma Education in the Healthcare Field: A Program Design Madison Walsh, MSc1, Dr. Cara Anne Poland, MD, MEd1; (1)Michigan State University

The Impact of Near-Peer Teaching on a Naloxone Training Workshop and Opioid Overdose Simulation Jachua Polcyn, MD Candidate1, Nicole Rockich-Winston, PharmD1; (1)Medical College of Georgia at Augusta University

The OSU System-Wide Addiction Services Program – Bolstering a Tertiary Care Center’s Addiction Safety Net Martin Clendenning Fried, MD, FACP; Ohio State University

The Problem Posed By the Lack of Racial Diversity in Co-Occurring Substance Use and Posttraumatic Stress Disorder Research Mallet R. Reid, PhD Candidate; Michigan State University

The Role of Hospital Climate and Nurse Stigma on Implementation of Chestfeeding and Skin-to-Skin Care for Neonatal Opioid Withdrawal Syndrome Clayton J Shuman, PhD, MSN, RN; University of Michigan

Toward a Deeper Understanding of Suicides That Follow Prescription Opioid Reduction in Pain: Preliminary Results from 19 Psychological Autopsies Stefan G Kertesz, MD; Birmingham Alabama Veterans Health Care System

Towards a Consensus on Strategies to Support Opioid Use Disorder Care Transitions Following Hospitalization: A Modified Delphi Process Noa Krawczyk, PhD; New York University Grossman School of Medicine

Trends in Nonfatal Opioid Overdose Among Veterans Health Administration Patients with Opioid Use Disorder Following COVID-Related Policy Changes for Opioid Use Disorder Treatment Madeline C Frost, MPH, PhD; Veterans Affairs Puget Sound Healthcare System

Understanding Resiliency in People Who Use Methamphetamine Demographically Matched to Acute Stimulant Toxicity Decedents Nigel Anderson; San Francisco Department of Public Health 

Unravelling the Opioid Crisis in Urban Centers: Community Strategies to Address Overdose Deaths in Boston, MA Evans F Kyei, BSN, MSN, PhD Candidate, RN; University of Massachusetts Boston

US and Canadian Medical Student Attitudes Toward People Who Inject Drugs: An Online Survey Tucker Avra1, Andrew Nelson, Medical Student2; (1)David Geffen School of Medicine at UCLA, (2)A.T. Still University School of Osteopathic Medicine

We Have the Right to Know: Building a Drug User-Owned Drug Checking Network in Texas Claire M Zagorski, MSc, LP; The University of Texas at Austin College of Pharmacy

What a Difference This Home Makes: Changes in Drug Use, HIV Risk and Prevention Behaviors Among Residents Relocated from Encampments to Low-Threshold Harm Reduction Housing Sites in Boston Traci C Green, MSc, PhD; Brandeis University

Would We, Could We? Measuring Attitudinal and Capacity Barriers to Supporting Residents on MOUD in Recovery Housing Rachel Winograd, PhD; University of Missouri, St. Louis

Xylazine-Associated Wounds Among Hospitalized Patients in Philadelphia Lydia Lutz, MD; Johns Hopkins University School of Medicine

Expanding Access to Addiction Knowledge: Engaging High School Students with Addiction Medicine Content Sophia Many Ly, Medical Student1, Amanda Marie Fitzpatrick, Medical Student, MPH1; (1)Boston Medical Center

Medications for Alcohol Use Disorder and Withdrawal: A National Sample of Patients Discharged from the Emergency Department Kathryn Hawk, MD, MHS; Yale University School of Medicine

Seeking Solutions: The Role of Behaviors and Personal and Social Beliefs in College Alcohol Help-Seeking Intent Benjamin N Montemayor, PhD; Texas A&M University School of Public Health

From Evidence to Action: A Retrospective Chart Review of Prescribing Factors Associated with Extended-Release Buprenorphine Retention in an Integrated Clinic Setting Sami Hamdan, MD, MPH1, Kenneth L. Morford, MD1; (1)Yale University School of Medicine

Leveraging Community Advisory Boards (CABs) to Enhance the Uptake of Harm Reduction Initiatives in West Philadelphia Jasmine S Barnes, MPH; University of Pennsylvania

Patterns of Opioid Misuse and Related Clinical Signs Among Veterans with Subsyndromal Opioid Use Disorder: A Latent Class Analysis Jayden Yu Henneman, BA; University of Michigan

Copyright © 2025
Site by: web360